BVD2-23B6 is the innovative therapeutic approach intended to selectively neutralize individual GM-CSF. Engineered via advanced immune agent creation methods, this agent demonstrates substantial binding to remarkable https://www.targetmol.com/compound/anti-human-gm-csf-antibody-bvd2-23b6